Abcellera Biologics Inc.

ABCL·NASDAQ·$5.29Share Price as of 11/2·$2BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/05/26 10-QQ1 ended 03/31/2605/11/26 10-KFY 202502/24/26 10-QQ3 ended 09/30/2511/06/25 10-QQ2 ended 06/30/2508/07/25

Disclosures

8-KCurrent report08/13/26 8-KCurrent report08/10/26 8-KCurrent report08/07/26 8-KCurrent report08/05/26 8-KCurrent report07/29/26

Prospectuses and Registrations

424B5Prospectus supplement08/13/26 424B5Prospectus supplement08/11/26 S-8Registration of securities for employees02/24/26 S-3ASRAutomatic shelf registration02/27/25 S-8Registration of securities for employees02/27/25

Proxies

DEF 14ADefinitive proxy04/29/26 DEFA14AAdditional proxy materials04/29/26 DEF 14ADefinitive proxy04/29/25 DEFA14AAdditional proxy materials04/29/25 DEF 14ADefinitive proxy04/29/24

Ownership

Form 4Insider transaction08/24/26 Form 4Insider transaction08/18/26 Form 4Insider transaction08/14/26 Form 4Insider transaction08/14/26 Form 4Insider transaction08/13/26

Other

ARSAnnual report to shareholders04/29/26 ARSAnnual report to shareholders04/29/25 ARSAnnual report to shareholders04/29/24 ARSAnnual report to shareholders04/28/23 EFFECTRequest for effectiveness08/11/22